Astera Labs (NASDAQ: ALAB) and Arm Holdings (NASDAQ: ARM) both occupy critical roles in the AI-driven semiconductor ecosystem, but their business models differ in meaningful ways.
Astera Labs specializes in hardware connectivity solutions designed to eliminate bottlenecks inside massive AI data centers used by hyperscale cloud providers.
Arm, by contrast, licenses processor architecture blueprints to chip designers and device manufacturers across virtually every segment of the global technology industry.
Astera Labs posted revenue of approximately $852.5 million for the fiscal year ended December 31, 2025, representing growth of nearly 115.1% compared to the prior year.
The company also reported net income of nearly $219.1 million, marking a dramatic turnaround from the net loss it recorded in the previous fiscal year.
Free cash flow came in close to $281.8 million, though stock-based compensation accounted for roughly 50.1% of operating cash flow, which inflates the reported figure.
Arm generated revenue of nearly $4.9 billion for the fiscal year ended March 31, 2026, reflecting growth of approximately 22.8% compared to the prior fiscal year.
Arm’s trailing free cash flow through the fiscal first quarter ending in June reached roughly $1.5 billion, with stock-based compensation representing about 69.0% of operating cash flow.
Astera Labs carries significant customer concentration risk, with its top three clients accounting for roughly 86% of total revenue in 2025, making the business vulnerable to the loss of any single hyperscaler.
Arm faces its own competitive threats, including the rise of the open-source RISC-V architecture, which offers a free alternative to its proprietary licensing model.
Both companies carry a debt-to-equity ratio of approximately 0.0x, reflecting minimal reliance on borrowed capital to fund their operations.
On valuation, Astera Labs trades at a forward price-to-earnings multiple of 84.3x and a price-to-sales ratio of 66.7x, while Arm commands higher multiples of 128.6x and 62.2x respectively.
Operating profit at Astera Labs exploded 546% year over year on a trailing-12-month basis to $273 million, pointing to strong and accelerating margin expansion.
Arm’s slower growth rate of around 25% contrasts with Astera’s year-over-year revenue doubling, suggesting Astera carries more near-term upside if AI infrastructure spending holds firm.
Given its stronger revenue growth trajectory, rapidly expanding margins, and relatively lower forward earnings multiple, Astera Labs appears to offer greater upside potential than Arm over the next few years.
